JOURNAL ARTICLE

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

Keywords:
Medicine Capecitabine Bevacizumab Neoadjuvant therapy Colorectal cancer Radiation therapy Internal medicine Cancer Gastroenterology Proctitis Oncology Chemotherapy Breast cancer Disease

Metrics

49
Cited By
3.75
FWCI (Field Weighted Citation Impact)
37
Refs
0.93
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Colorectal Cancer Surgical Treatments
Health Sciences →  Medicine →  Oncology
Colorectal and Anal Carcinomas
Health Sciences →  Medicine →  Surgery
Colorectal Cancer Treatments and Studies
Health Sciences →  Medicine →  Oncology

Related Documents

JOURNAL ARTICLE

Triweekly XELOX Versus Single Capecitabine Concomitant with Neoadjuvant Radiotherapy for Locally Advanced Rectal Cancer

A. LiBenhua Xu

Journal:   International Journal of Radiation Oncology*Biology*Physics Year: 2020 Vol: 108 (3)Pages: e658-e658
© 2026 ScienceGate Book Chapters — All rights reserved.